Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
BRD4 promotes endodermal cell fate during mammalian lung development
Hongbo Wen, Derek C. Liberti, Prashant Chandrasekaran, Shahana Parveen, Kwaku K. Quansah, Mijeong Kim, Ana N. Lange, Abigail T. Marquis, Sylvia N. Michki, Annabelle Jin, MinQi Lu, Ayomikun A. Fasan, Sriyaa Suresh, Shawyon P. Shirazi, Lisa R. Young, Jennifer M.S. Sucre, Maria C. Basil, Rajan Jain, David B. Frank
Hongbo Wen, Derek C. Liberti, Prashant Chandrasekaran, Shahana Parveen, Kwaku K. Quansah, Mijeong Kim, Ana N. Lange, Abigail T. Marquis, Sylvia N. Michki, Annabelle Jin, MinQi Lu, Ayomikun A. Fasan, Sriyaa Suresh, Shawyon P. Shirazi, Lisa R. Young, Jennifer M.S. Sucre, Maria C. Basil, Rajan Jain, David B. Frank
View: Text | PDF
Research Article Development Pulmonology

BRD4 promotes endodermal cell fate during mammalian lung development

  • Text
  • PDF
Abstract

Lung development relies on diverse cell intrinsic and extrinsic mechanisms to ensure proper cellular differentiation and compartmentalization. In addition, it requires precise integration of multiple signaling pathways to temporally regulate morphogenesis and appropriate cell specification. To accomplish this, organogenesis relies on epigenetic and transcriptional regulators to promote cell fate and inhibit alternative cell fates. Using genetic mouse and human embryonic stem cell (hESC) differentiation models, tissue explants, and single-cell transcriptomic analysis, we demonstrated that Bromodomain Containing Protein 4 (BRD4) is required for mammalian lung morphogenesis and cell fate. Endodermal deletion of BRD4 impaired epithelial-mesenchymal crosstalk, leading to disrupted proximal-distal patterning and branching morphogenesis. Moreover, temporal deletion of BRD4 revealed developmental stage–specific defects in airway and alveolar epithelial cell specification with a predominant role in proximal airway cell fate. Similarly, BRD4 promoted lung endodermal cell differentiation into airway lineages in a hESC-derived lung organoid model. Together, these data demonstrate that BRD4 orchestrates early lung morphogenesis and separately regulates cell specification, indicating a multifunctional and evolutionarily conserved role for BRD4 in mammalian lung development.

Authors

Hongbo Wen, Derek C. Liberti, Prashant Chandrasekaran, Shahana Parveen, Kwaku K. Quansah, Mijeong Kim, Ana N. Lange, Abigail T. Marquis, Sylvia N. Michki, Annabelle Jin, MinQi Lu, Ayomikun A. Fasan, Sriyaa Suresh, Shawyon P. Shirazi, Lisa R. Young, Jennifer M.S. Sucre, Maria C. Basil, Rajan Jain, David B. Frank

×

Figure 8

BRD4 bromodomains inhibition disrupts hESC-derived lung endodermal cell fate.

Options: View larger image (or click on image) Download as PowerPoint
BRD4 bromodomains inhibition disrupts hESC-derived lung endodermal cell ...
(A) Experimental schematic indicating each step of deriving hESCs into airway organoids with components of the media. Red arrow indicates the day when JQ1 treatment begins. (B) Overlapped bright-field and fluorescent images of hESC-derived airway organoids with SCGB3A2mCherry reporter on the day of harvest between DMSO (left) and JQ1 (right) treatment. Scale bar: 1 mm. (C) H&E of tissue sections of organoids treated with DMSO and JQ1. (D–F) Quantification of percentage of mCherry positive organoids (D), colony forming efficiency (E), and organoid diameter (F) between DMSO and JQ1 treatment. Each dot represents an individual differentiation experiment. Quantification data are represented as mean ± SEM. Two tailed t tests: *P ≤ 0.05, **P ≤ 0.01, n ≥ 3. (G) qPCR analysis of secretory cell marker genes, SCGB3A2 and SCGB1A1 (top), ciliated cell marker gene, FOXJ1 (bottom left) and basal cell marker gene, TP63 (bottom right) between DMSO (blue) and JQ1 (red) treatment. Each dot represents an individual differentiation experiment. Quantification data are represented as mean ± SEM. Two-tailed t test: *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, n = 4. (H) IHC for (left) SCGB3A2, (middle) FOXJ1, and (right) TP63 in DMSO- and JQ1-treated hESC-derived airway organoids. Scale bars: 20 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts